HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

Go back to HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.72 +0.29 (67.44%)
Previous Close $0.43    52 Week High $21.68 
Open $0.75    52 Week Low $8.74 
Day High $0.94    P/E N/A 
Day Low $0.66    EPS $-0.46 
Volume 257,605,398